Andreas Kurth

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher et al. · The Lancet · 2007 · 1.1K citations

Medicine, Orthopedic Surgery, Pharmacotherapy +15

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

Bengt I. Eriksson, O.E. Dahl, Nadia Rosencher et al. · Journal of Thrombosis and Haemostasis · 2007 · 984 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells

Scott P. Bruder, Andreas Kurth, Marie Shea et al. · Journal of Orthopaedic Research® · 1998 · 758 citations

Engineering, Orthopaedic Surgery, Orthopedic Surgery +17

Bone health in cancer: ESMO Clinical Practice Guidelines

Robert E. Coleman, Peyman Hadji, Jean‐Jacques Body et al. · Annals of Oncology · 2020 · 518 citations · Full text

Medicine, Oncology, Pharmacology +17

Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)

Ola Dahl, Michael H. Huo, Andreas Kurth et al. · Thrombosis and Haemostasis · 2011 · 399 citations

Medicine, Orthopaedic Surgery, Surgery +17